quaternary ammonium β-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the...

1
2009, Volume 10 Eun Seok Gil, Jianshu Li, Huining Xiao, and Tao Lu Lowe*: Quaternary Ammonium -Cyclodextrin Nano- particles for Enhancing Doxorubicin Permeability across the In Vitro Blood-Brain Barrier Page 506. Section 1, Introduction: The Reference 28 in the last paragraph is deleted. Page 506. Section 2.2, the synthesis protocol: correct to “Briefly, -CD (5 mmol, 5.675 g) was dissolved in NaOH aqueous solution (20 mL, 0.9 M) with stirring at 25 °C for 24 h. Choline chloride [2.5 mmol (0.349 g), 10 mmol (1.396 g), 20 mmol (2.792 g), or 30 mmol (4.189 g)] was subsequently fed into the solution and epichlorohydrin [75 mmol (6.939 g)] was added at a flow rate of about 0.1 mL · min -1 .” The concentration of hydrochloride acid solution: correct to 3 M. The denotation for each QACD: correct to “Each QACD is denoted as 1-W- N, where W and N denote the feeding molar ratios of epichlo- rohydrin to -CD and choline chloride to -CD, respectively.” Reference 28, correct to ref 40. Page 506. Section 2.3.1, the preparation of QACD nano- particle 1-15-2/DOX complexes: correct to “The QACD nanoparticle 1-15-2/DOX complexes were prepared by mixing QACD 1-15-2 (5 mg · mL -1 , 3.9 mM of CD unit) and DOX (2.1 mg · mL -1 , 3.9 mM) in D 2 O at 1:1 molar ratio of DOX to CD unit, and storing the mixture at 4 °C for overnight.” Page 514. Section 4, Discussion: The ref 28 in the second column, last paragraph: correct to ref 40. BM900279C 10.1021/bm900279c Published on Web 03/17/2009 Biomacromolecules 2009, 10, 1020 1020

Upload: tao-lu

Post on 13-Feb-2017

212 views

Category:

Documents


0 download

TRANSCRIPT

2009, Volume 10

Eun Seok Gil, Jianshu Li, Huining Xiao, and Tao LuLowe*: Quaternary Ammonium �-Cyclodextrin Nano-particles for Enhancing Doxorubicin Permeabilityacross the In Vitro Blood-Brain Barrier

Page 506. Section 1, Introduction: The Reference 28 in thelast paragraph is deleted.

Page 506. Section 2.2, the synthesis protocol: correct to“Briefly, �-CD (5 mmol, 5.675 g) was dissolved in NaOHaqueous solution (20 mL, 0.9 M) with stirring at 25 °C for 24 h.Choline chloride [2.5 mmol (0.349 g), 10 mmol (1.396 g), 20mmol (2.792 g), or 30 mmol (4.189 g)] was subsequently fedinto the solution and epichlorohydrin [75 mmol (6.939 g)] wasadded at a flow rate of about 0.1 mL ·min-1.” The concentrationof hydrochloride acid solution: correct to 3 M. The denotationfor each QA�CD: correct to “Each QA�CD is denoted as 1-W-N, where W and N denote the feeding molar ratios of epichlo-rohydrin to �-CD and choline chloride to �-CD, respectively.”Reference 28, correct to ref 40.

Page 506. Section 2.3.1, the preparation of QA�CD nano-particle 1-15-2/DOX complexes: correct to “The QA�CDnanoparticle 1-15-2/DOX complexes were prepared by mixingQA�CD 1-15-2 (5 mg ·mL-1, 3.9 mM of �CD unit) and DOX(2.1 mg ·mL-1, 3.9 mM) in D2O at 1:1 molar ratio of DOX to�CD unit, and storing the mixture at 4 °C for overnight.”

Page 514. Section 4, Discussion: The ref 28 in the secondcolumn, last paragraph: correct to ref 40.

BM900279C

10.1021/bm900279cPublished on Web 03/17/2009

Biomacromolecules 2009, 10, 10201020